Allegion CFO granted stock options and RSUs

Wagnes Michael J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Wagnes Michael J. reported acquisition or exercise transactions in this Form 4 filing.

Allegion plc reported that its SVP and CFO, Michael J. Wagnes, received new equity awards on February 19, 2026. He was granted stock options for 9,329 shares and 2,460 ordinary shares in the form of restricted stock units as part of his compensation.

The restricted stock units vest in three equal annual installments on February 19, 2027, 2028, and 2029. The stock option grant vests on the same schedule. After these awards, Wagnes directly holds 32,642 ordinary shares and 9,329 stock options.

Insider Trade Summary

Grant/Award: 11,789 shares

Grant/Award 2 txns

Insider Wagnes Michael J.

Role SVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	9,329	$0.00	$0.00
Grant/Award	Ordinary Shares	2,460	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 9,329 contracts (Direct); Ordinary Shares — 32,642 shares (Direct)

Footnotes (2)

1. F1. Restricted stock units that vest in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029.
2. F2. A stock option that vests in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Allegion (ALLE) report for CFO Michael J. Wagnes?

Allegion reported that CFO Michael J. Wagnes received equity awards on February 19, 2026. He was granted 9,329 stock options and 2,460 ordinary shares as restricted stock units, reflecting compensation awards rather than open-market stock purchases or sales.

How many stock options were granted to Allegion (ALLE) CFO Michael J. Wagnes?

Michael J. Wagnes was granted stock options covering 9,329 Allegion ordinary shares on February 19, 2026. These options vest in three equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029, aligning with a multi-year incentive structure.

What restricted stock unit (RSU) grant did Allegion (ALLE) disclose for its CFO?

Allegion disclosed that CFO Michael J. Wagnes received 2,460 ordinary shares in the form of restricted stock units on February 19, 2026. These RSUs vest in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029, subject to continued service.

What is the vesting schedule for Allegion (ALLE) CFO Michael J. Wagnes’s new equity awards?

Both the restricted stock units and the stock options awarded to Michael J. Wagnes vest in three equal annual installments. Vesting dates are February 19, 2027, February 19, 2028 and February 19, 2029, creating a staggered, multi-year vesting timeline for these compensation grants.

How many Allegion (ALLE) ordinary shares does Michael J. Wagnes hold after these grants?

Following the February 19, 2026 transactions, Michael J. Wagnes directly owns 32,642 Allegion ordinary shares. This figure reflects his share balance after the grant of 2,460 restricted stock units, as reported in the Form 4 insider transaction filing.

Are the Allegion (ALLE) CFO’s Form 4 transactions market purchases or compensation awards?

The Form 4 transactions are compensation awards, not market trades. Michael J. Wagnes received 9,329 stock options and 2,460 restricted stock units as grants or awards, with no purchase price disclosed, and vesting annually from February 19, 2027 through February 19, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 03:22 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagnes Michael J.

(Last) (First) (Middle)

C/O SCHLAGE LOCK COMPANY LLC

11819 N. PENNSYLVANIA STREET

(Street)

CARMEL IN 46032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Allegion plc [ ALLE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/19/2026		A		2,460(1)	A	$0	32,642	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$162.665	02/19/2026		A		9,329		(2)	02/19/2036	Ordinary Shares	9,329	$0	9,329	D

Explanation of Responses:

1. Restricted stock units that vest in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029.

2. A stock option that vests in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029.

Remarks:

	/s/ Tandra M. Foster, Attorney-In-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.